CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea - Newswise

JSF-2659, developed to be administered orally, could be a game changer in treating Neisseria gonorrhoeae, which is on the World Health Organization’s global l

Newswise — Nutley, NJ, August 23, 2022 – A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicati… [+5792 chars]

full article...